[HTML][HTML] Rapamycin: drug repurposing in SARS-CoV-2 infection

J Patocka, K Kuca, P Oleksak, E Nepovimova, M Valis… - Pharmaceuticals, 2021 - mdpi.com
Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with
enormous consequences for human health and the world economy. Remdesivir is the only …

[HTML][HTML] Review of epidemic, containment strategies, clinical management, and economic evaluation of COVID-19 pandemic

CL Chen, CC Lai, DL Luh, SY Chuang, KC Yang… - Journal of the Formosan …, 2021 - Elsevier
The spread of the emerging pathogen, named as SARS-CoV-2, has led to an
unprecedented COVID-19 pandemic since 1918 influenza pandemic. This review first sheds …

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome

I Levy, A Lavi, E Zimran, S Grisariu… - Leukemia & …, 2021 - Taylor & Francis
This national Israeli multicenter retrospective study aimed to characterize the clinical course
of COVID-19 infection among patients with hematological malignancies, with special …

An emerging natural antioxidant therapy for COVID‐19 infection patients: Current and future directions

AK Shrivastava, PK Sahu, T Cecchi, L Shrestha… - Food …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) affects millions of people
worldwide. The article aims to review the therapeutic perspective on natural antioxidants …

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

S Kumar, M Basu, P Ghosh, U Pal, MK Ghosh - Genes & diseases, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the complicated
disease COVID-19. Clinicians are continuously facing huge problems in the treatment of …

Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor

KV Nguyen - Nucleosides, Nucleotides & Nucleic Acids, 2021 - Taylor & Francis
The outbreak of a novel coronavirus responsible for the severe acquired respiratory
syndrome: SARS-CoV-2, also known as coronavirus disease 2019: COVID-19, represents a …

[图书][B] The Covid-19 pandemic and global bioethics

H ten Have - 2022 - Springer
The emergence of Covid-19 is a perfect example of a global phenomenon that affects
everybody across the world. In 2020, it demonstrated its powerful effects on human well …

[HTML][HTML] COVID-19: Management of adults with acute illness in the outpatient setting

P Cohen, K Gebo - UpToDate. UpToDate, 2023 - medilib.ir
INTRODUCTION—At the end of 2019, a novel coronavirus rapidly spread throughout the
world, resulting in a global pandemic. The virus was designated severe acute respiratory …

Antiviral treatment selection for SARS-CoV-2 pneumonia

M Bassetti, S Corcione, S Dettori… - Expert Review of …, 2021 - Taylor & Francis
Introduction Therapy of coronavirus disease 2019 (COVID-19) involves evolving algorithms
that include drugs aimed at reducing disease progression by counteracting two different, but …

[HTML][HTML] COVID-19: A game of drugs, vaccines, hope and… death!

A Samantaray, E Johnson, N Kumar… - Indian Journal of …, 2021 - journals.lww.com
435 Indian Journal of Anaesthesia| Volume 65| Issue 6| June 2021 the disease was in fact
highly vasculo-inflammatory and thrombogenic in nature [5] and could lead to complications …